OConnell Daniel Joseph — SEC Form 4 filings
SEC reporting owner CIK 1865136. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-23.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-19 to 2026-01-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 6 filings — 161,610 shares, $323,852 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 47,778 shares @ $1.84 ($87,873) in Acumen Pharmaceuticals, Inc., filed 2025-01-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | Chief Executive Officer, Director | 7 | — | 11 legs · 161,610 sh · $323,852 | 4 |
Form 4 filings — OConnell Daniel Joseph
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-23 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 9,346 @ $1.81 · Sale (S): 2,689 @ $1.88 | EDGAR |
| 2026-01-21 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/award (A): 299,800 @ $0 · Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 8,143 @ $1.82 · Sale (S): 12,941 @ $1.76 · Sale (S): 5,388 @ $1.73 | EDGAR |
| 2026-01-07 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 4,649 @ $1.97 · Sale (S): 5,102 @ $1.97 · Sale (S): 37,755 @ $1.99 | EDGAR |
| 2025-01-23 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 12,619 @ $1.59 | EDGAR |
| 2025-01-07 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 47,778 @ $1.84 · Grant/award (A): 225,400 @ $0 · Grant/award (A): 338,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 15,200 @ $3.47 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1865136 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →